New immunotherapy treatment shows positives signs for mesothelioma patients

Mesothelioma patients have some treatment options that can prolong and improve the quality of their lives, but there is no cure. Now researchers in Australia have begun researching a new immuno-therapy technique which may possibly inhibit tumor growth.

Manfred Beilharz, a researcher and professor at the University of Western Australia, has developed a technique he refers to as “triple therapy.” According to Beilharz, this therapy involves manipulation the immune system in three different ways, which has shown to positive results in laboratory mice.

The therapy involves strengthening the “three arms” of the immune system defense process. In the past, single and double immunotherapy has had its benefits, but has not been a cure. Targeting three areas of the immune system have shown to defeat cancer cells in experiments.

Beilharz hopes to move into clinical trials using human subjects for testing.

Beilharz grew up in a community where he witnessed the detriments of asbestos exposure, the known cause of mesothelioma. Industrial and construction workers are a group of people vulnerable to asbestos-related diseases and often hire mesothelioma attorneys to obtain fund necessary for medical treatment.

Manufacturers of materials containing asbestos have been knowingly exposed people to this carcinogen without warning. Mesothelioma lawyers have been successful at holding these companies accountable for the harm they caused in civil courts.

Mesothelioma patients suffer a great deal of pain, which could have been avoided if they had been warned of the dangers. The diligent work of medical professionals and mesothelioma attorneys has led to protections for workers who work around asbestos.